Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Eli Lilly
LLY
|
$797M |
| 2 |
American Tower
AMT
|
$699M |
| 3 |
Novo Nordisk
NVO
|
$556M |
| 4 |
Abbott
ABT
|
$529M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$401M |
Top Sells
| 1 |
Shopify
SHOP
|
$777M |
| 2 |
Netflix
NFLX
|
$643M |
| 3 |
Match Group
MTCH
|
$583M |
| 4 |
NVIDIA
NVDA
|
$490M |
| 5 |
Adobe
ADBE
|
$456M |
Sector Composition
| 1 | Technology | 28.24% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.79% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
551
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $751K | ﹤0.01% |
+13,151
| New | +$751K |
|
552
Lincoln National
LNC
$7.98B
| $747K | ﹤0.01% |
+15,976
| New | +$747K |
|
553
Crown Castle
CCI
$41.9B
| $742K | ﹤0.01% |
4,408
+3,048
| +224% | +$513K |
|
554
J.M. Smucker
SJM
$12B
| $738K | ﹤0.01% |
5,762
+1,197
| +26% | +$153K |
|
555
GMS Inc
GMS
| $737K | ﹤0.01% |
+16,558
| New | +$737K |
|
|
AEL
556
DELISTED
American Equity Investment Life Holding Company
AEL
| $728K | ﹤0.01% |
+19,896
| New | +$728K |
|
557
TTM Technologies
TTMI
$4.93B
| $709K | ﹤0.01% |
+56,748
| New | +$709K |
|
558
Amicus Therapeutics
FOLD
$2.46B
| $707K | ﹤0.01% |
65,788
-3,502,726
| -98% | -$37.6M |
|
559
Matador Resources
MTDR
$6.01B
| $700K | ﹤0.01% |
15,029
-476
| -3% | -$22.2K |
|
560
Bandwidth Inc
BAND
$473M
| $694K | ﹤0.01% |
36,889
+291
| +0.8% | +$5.48K |
|
561
Matsons
MATX
$3.36B
| $693K | ﹤0.01% |
9,502
-3,518
| -27% | -$257K |
|
562
Green Brick Partners
GRBK
$3.2B
| $689K | ﹤0.01% |
+35,198
| New | +$689K |
|
563
Vanguard Growth ETF
VUG
$186B
| $689K | ﹤0.01% |
3,091
+1,254
| +68% | +$280K |
|
564
Newmark Group
NMRK
$3.28B
| $687K | ﹤0.01% |
71,068
+20,940
| +42% | +$202K |
|
565
Dorian LPG
LPG
$1.33B
| $678K | ﹤0.01% |
+44,624
| New | +$678K |
|
|
ATSG
566
DELISTED
Air Transport Services Group, Inc.
ATSG
| $678K | ﹤0.01% |
+23,608
| New | +$678K |
|
567
Pacific Biosciences
PACB
$381M
| $677K | ﹤0.01% |
153,165
+70,949
| +86% | +$314K |
|
|
MDRX
568
DELISTED
Veradigm Inc. Common Stock
MDRX
| $675K | ﹤0.01% |
45,489
-4,496
| -9% | -$66.7K |
|
569
Morningstar
MORN
$10.8B
| $671K | ﹤0.01% |
2,774
-2,129
| -43% | -$515K |
|
570
Cognizant
CTSH
$35.1B
| $663K | ﹤0.01% |
9,823
+4,932
| +101% | +$333K |
|
571
AMN Healthcare
AMN
$799M
| $655K | ﹤0.01% |
5,970
-3,629
| -38% | -$398K |
|
572
Prothena Corp
PRTA
$460M
| $652K | ﹤0.01% |
24,016
-29
| -0.1% | -$787 |
|
|
AQUA
573
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $652K | ﹤0.01% |
20,068
+489
| +2% | +$15.9K |
|
574
Sinclair Inc
SBGI
$964M
| $650K | ﹤0.01% |
+31,843
| New | +$650K |
|
|
NEX
575
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $642K | ﹤0.01% |
+67,501
| New | +$642K |
|